Search Articles — Sudonull

Search Results

From other projects

EMA accepted the application for Dovato for children with HIV

https://ymaho.com/ema-accepted-the-application-for-dovato-for-children-with-hiv

EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.

Gene therapy OPGx-LCA5 accepted into FDA RDEP program

https://ymaho.com/gene-therapy-opgx-lca5-accepted-into-fda-rdep-program

Learn how Opus Genetics' gene therapy OPGx-LCA5 received RDEP status from the FDA, accelerating the development of treatment for ultra-rare LCA5 blindness in children. Detailed analysis and prospects.

Gene therapy for deafness otarmeni EMA: accelerated review 2026

https://ymaho.com/gene-therapy-for-deafness-otarmeni-ema-accelerated-review-2026

EMA accepted the application for gene therapy otarmeni for the treatment of hereditary deafness OTOF. Market analysis, forecasts, price and implications for the industry. Read.

The concept of Well-aging: healthy aging

https://ymaho.com/the-concept-of-well-aging-healthy-aging

Well-aging is replacing anti-aging: how acceptance of age and health care are changing the beauty market in 2026. Learn key trends.

Trending Now